JD
The startup develops a cell-free DNA-based noninvasive prenatal testing technology that enables in-home genetic testing through cost-effective devices. This approach eliminates the need for phlebotomy and significantly reduces the costs and lead times associated with traditional prenatal testing, providing women and their physicians with timely access to essential health information.
Updated 3 months ago
Funding
$31M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a cell-free DNA-based noninvasive prenatal testing technology that enables in-home genetic testing through cost-effective devices. This approach eliminates the need for phlebotomy and significantly reduces the costs and lead times associated with traditional prenatal testing, providing women and their physicians with timely access to essential health information.